ConductScience.org, home

Paper19821398

Blood pressure lowering efficacy of diuretics as second-line therapy for primary hypertension.

Chen JM and 2 others. Cochrane Database Syst Rev, 2009. Cited by 19 papers, by iCite.

Cite this record

ConductScience Library. Blood pressure lowering efficacy of diuretics as second-line therapy for primary hypertension. Papers, record 19821398. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/19821398

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Blood pressure lowering efficacy of diuretics as second-line therapy for primary hypertension.
PubMed
Journal
Cochrane Database Syst Rev
PubMed
Year
2009
PubMed
Publication types
Journal Article, Meta-Analysis, Systematic Review
PubMed
Citations, by iCite
19
iCite
Relative citation ratio, by iCite
0.64
iCite
Revised in PubMed
2025-09-06
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Chen JMJenny Mh
2Heran BSBalraj S
3Wright JMJames M

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antihypertensive AgentsMajor topic
DiureticsMajor topic
HypertensionMajor topic
Sodium Chloride Symporter InhibitorsMajor topic
Sodium Potassium Chloride Symporter InhibitorsMajor topic
Blood Pressure
Drug Therapy, Combination
Heart Rate
Humans
Randomized Controlled Trials as Topic

Source PubMed

Download CSV of topics

References123

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
18249842Usefulness of piretanide plus ramipril for systemic hypertension: a multicenter trial.Am J Cardiol1993https://conductscience.org/library/papers/8249842PubMed
23326920Captopril and nifedipine interactions in the treatment of essential hypertensives: a crossover study.J Hypertens Suppl1987https://conductscience.org/library/papers/3326920PubMed
315001200Evaluation of antihypertensive therapy with the combination of olmesartan medoxomil and hydrochlorothiazide.Am J Hypertens2004https://conductscience.org/library/papers/15001200PubMed
47564362Double-blind comparison of antihypertensive treatment with ramipril and piretanide, given alone or in combination.J Cardiovasc Pharmacol1995https://conductscience.org/library/papers/7564362PubMed
512959310The antihypertensive efficacy and tolerability of a low dose combination of ramipril and felodipine ER in mild to moderate essential hypertension.Br J Clin Pharmacol1993https://conductscience.org/library/papers/12959310PubMed
610229744Changes in arterial structure and function under trandolapril-verapamil combination in hypertension.Stroke1999https://conductscience.org/library/papers/10229744PubMed
718800455Losartan with hydrochlorothiazide in the treatment of hypertension.J Hypertens Suppl1995https://conductscience.org/library/papers/18800455PubMed
87049710Clinical evaluation of labetalol alone and combined with chlorthalidone in essential hypertension: a double-blind multicentre controlled study.Eur J Clin Pharmacol1982https://conductscience.org/library/papers/7049710PubMed
918843651Blood pressure lowering efficacy of angiotensin converting enzyme (ACE) inhibitors for primary hypertension.Cochrane Database Syst Rev2008https://conductscience.org/library/papers/18843651PubMed
101597846A dose escalation trial comparing the combination of diltiazem SR and hydrochlorothiazide with the monotherapies in patients with essential hypertension.J Hum Hypertens1992https://conductscience.org/library/papers/1597846PubMed
116412795Effect on intra-arterial blood pressure of slow release metoprolol combined with placebo or chlorthalidone.Br Med J (Clin Res Ed)1983https://conductscience.org/library/papers/6412795PubMed
122442550
Controlled multicenter study of the antihypertensive effects of lisinopril, hydrochlorothiazide, and lisinopril plus hydrochlorothiazide in the treatment of 394 patients with mild to moderate essential hypertension.
J Cardiovasc Pharmacol1987https://conductscience.org/library/papers/2442550PubMed
138385183Short report: ramipril and hydrochlorothiazide combination therapy in hypertension: a clinical trial of factorial design. The East Germany Collaborative Trial Group.J Hypertens1993https://conductscience.org/library/papers/8385183PubMed
14323525Propranolol in the treatment of essential hypertension.JAMA1977https://conductscience.org/library/papers/323525PubMed
158880557Double-blind, parallel, comparative multicentre study of a new combination of diltiazem and hydrochlorothiazide with individual components in patients with mild or moderate hypertension.J Hum Hypertens1996https://conductscience.org/library/papers/8880557PubMed
1610480473Matrix study of irbesartan with hydrochlorothiazide in mild-to-moderate hypertension.Am J Hypertens1999https://conductscience.org/library/papers/10480473PubMed
179331013Dose-finding study of candesartan cilexetil plus hydrochlorothiazide in patients with mild to moderate hypertension.J Hum Hypertens1997https://conductscience.org/library/papers/9331013PubMed
188247917A randomized, controlled trial comparing diltiazem, hydrochlorothiazide, and their combination in the therapy of essential hypertension.Pharmacotherapy1993https://conductscience.org/library/papers/8247917PubMed
19378094The fixed combination of propranolol and bendrofluazide in the treatment of hypertension.Ann Clin Res1979https://conductscience.org/library/papers/378094PubMed
20799563Evaluation of the effect of timolol alone and in combination with hydrochlorothiazide and amiloride in the treatment of mild to moderate arterial hypertension: a double-blind, controlled study.Clin Sci Mol Med Suppl1976https://conductscience.org/library/papers/799563PubMed

See all 123 referencesDownload CSV of references

Cited by7

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 19 citations.

PMIDTitleJournalYearIn PapersSource
26000442Blood pressure-lowering efficacy of loop diuretics for primary hypertension.Cochrane Database Syst Rev2015https://conductscience.org/library/papers/26000442PubMed
24869750Blood pressure-lowering efficacy of monotherapy with thiazide diuretics for primary hypertension.Cochrane Database Syst Rev2014https://conductscience.org/library/papers/24869750PubMed
24504763Antihypertensive medications, bone mineral density, and fractures: a review of old cardiac drugs that provides new insights into osteoporosis.Endocrine2014https://conductscience.org/library/papers/24504763PubMed
24381822Effects of eurythmy therapy in the treatment of essential arterial hypertension: a pilot study.Glob Adv Health Med2013https://conductscience.org/library/papers/24381822PubMed
23152254Blood pressure lowering efficacy of potassium-sparing diuretics (that block the epithelial sodium channel) for primary hypertension.Cochrane Database Syst Rev2012https://conductscience.org/library/papers/23152254PubMed
20960021Augmented antihypertensive effect of a fixed combination formula of candesartan and hydrochlorothiazide combined with furosemide in a patient on peritoneal dialysis.Clin Exp Nephrol2011https://conductscience.org/library/papers/20960021PubMed
20091622Blood pressure lowering efficacy of beta-blockers as second-line therapy for primary hypertension.Cochrane Database Syst Rev2010https://conductscience.org/library/papers/20091622PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/19821398

GET https://conductscience.org/api/papers/v1/19821398/references?page=2